Cantor Fitzgerald Reiterates Overweight on HCA Healthcare, Maintains $392 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on HCA Healthcare, maintaining a price target of $392.
August 20, 2024 | 2:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on HCA Healthcare, maintaining a price target of $392.
The reiteration of an Overweight rating and a maintained price target of $392 by a reputable analyst can positively influence investor sentiment and potentially lead to a short-term increase in HCA's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100